Figure 3.
a) Differences between treatment groups in the VR-12 MCS at baseline, 3 months, 6 months, and 9 months, with reported p-value for group by time interaction. (b) Differences between low frequency exercisers in treatment groups in MCS at baseline, 3 months, and 6 months. (c) Differences between high frequency exercisers in treatment groups in MCS at baseline, 3 months, and 6 months, with p-value for group by time interaction. (d) Differences between low frequency exercisers in treatment groups in MCS at baseline, 3 months, 6 months, and 9 months. (e) Differences between high frequency exercisers in treatment groups in MCS at baseline, 3 months, 6 months, and 9 months, with p-value for group by time interaction. AU = arbitrary units, g = grams, d = day, MCS = mental component score, LF = low frequency, HF = high frequency.